// App-Quantinova.ai

: A novel, high sensitivity marker of cartilage formation was developed and tested in a phase ii clinical trial of PTH

Researchers

Presenter

  • Y.Y. Luo

Principal Investigators

  • Y. He

  • I. Byrjalsen

  • K. Henriksen

  • N.S. Gudmann

  • A. Mobasheri

  • G. Hansen

  • M. Karsdala

  • A.C. Bay-Jensen

Medical Centers

  • Nordic BioSci. A/S, Herlev, Denmark

  • D-BOARD EU Consortium for Biomarker Discovery, University of Surrey, United Kingdom

Locations

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Parathyroid Hormone

  • Procollagen I amino-terminal propeptide

Drug/Treatment

  • Teriparatide

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Open Label

  • Active Comparator

  • Controlled

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved